Kesh45
Posted - 22 hours ago
$ARDS come on Vu, sell this pos
Occitania
Posted - 1 day ago
$ARDS Timeframe : Weekly TRENDS Short term: STRONGLY BEARISH MY OPINION BEARISH UNDER 0.0710 USD MY TARGETS 0.0570 USD (-11.63%) MY ANALYSIS ARIDIS PHARMACEUTICALS ARDS is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 0.0710 USD. The next support located at 0.0570 USD is the next bearish objective to target. A bearish break of this support would revive the bearish momentum. With the current pattern, you will need to monitor for possible bearish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bearish trend. Trying to profit from the purchase of these possible corrections may seem risky.
Occitania
Posted - 6 days ago
$ARDS Astrazeneca ist nicht ards ards ist tod
Phaaisatroll
Posted - 6 days ago
$ARDS Astrazeneca is working on a new monoclonal antibody against c. difficile. Seems like its kinda the same as AR-301 and AR-320 because its an antibody against the toxin of this bacterium. https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-advances-the-science-of-infectious-disease-protection-at-eccmid-2024.html
ChiefOptionsTrader
Posted - 1 week ago
$ARDS If this is a buy out candidate stock, I can understand the silence.
Phaaisatroll
Posted - 1 week ago
$ARDS a bit surprising that Hepalink is saying nothing about the termination of AR-301 by Aridis in their annual report right? Is it normal to just ignore that? https://www.hkexnews.hk/listedco/listconews/sehk/2024/0328/2024032805461.pdf
kotatsu
Posted - 1 week ago
$ARDS A good CEO never kills common shareholders. How about Mr. Vu?
phaa
Posted - 1 week ago
$ARDS Looks like this stock is as dead as "bobby buyouts" theories
Phaaisatroll
Posted - 1 week ago
$ARDS she changed her LinkedIn today and found a new job.
kotatsu
Posted - 1 week ago
$ARDS I hope to see some results soon.
kotatsu
Posted - 1 week ago
$ARDS I'm tired of waiting.
ChiefOptionsTrader
Posted - 1 week ago
$ARDS Potential but out candidate? That would be nice if that were to happen. Surprised it is not setting new highs. Very few traders must know about this.
Phaaisatroll
Posted - 2 weeks ago
$ARDS Vu said up to 12 months for partnership discussions to be finished. I think we are near now.
ChiefOptionsTrader
Posted - 2 weeks ago
$ARDS why the big drop today? Someone selling?
Kesh45
Posted - 2 weeks ago
$ARDS at this point. i would be surprised if we ever hear from these clowns again.
Phaaisatroll
Posted - 2 weeks ago
$ARDS Astrazeneca is still interested in bacterial infections and they don't have much on their pipeline against antibiotic resistant bacteria. How can they change that?
Kesh45
Posted - 3 weeks ago
$ARDS
Phaaisatroll
Posted - 03/30/24
$ARDS why didn't we get anything for our Covid antibody and Gritstone gets $433 million for another vaccine?
Phaaisatroll
Posted - 03/29/24
$ARDS Astrazeneca is on their way to the World Vaccine Congress. Aridis assets would be the perfect addition to AZ's pipeline to solve the problem of antimicrobial resistance. Mark Esser is the AstraZeneca puppet that gave Suvratoxumab to Aridis and then destroyed the company. He has to solve the issue with Aridis or i will make sure that his reputation will also get damaged.
RallyRaider
Posted - 03/29/24
$ARDS recent presentation suggests its a nothing burger- what am i missing
RallyRaider
Posted - 03/29/24
$ARDS no Astrazeneca opt in yet? Was up like a few hundred percent a while ago on mere speculation.... employees on linkedin hinted at it like 1000 times?
DeadHeadDave
Posted - 03/28/24
$ARDS Gamida cell is the future of Aridis. Executives and board set themselves up by amending their compensation in the case of change of ownership. Declare bankruptcy, cancel the shares of retail, and hand the company 100% to their creditor. The private company gets an infusion of cash, executives keep their jobs, and retail gets $0.22 if company hits sales targets (not going to happen). Don't think Vuong won't do the same here.
Phaaisatroll
Posted - 03/28/24
$ARDS this document from 2022 shows that Europe is very interested in gallium and that a company in Europe should be able to get research support for the drug development of gallium against bacterial infections. Also interesting that also orphan drugs are included in this and are potentially able to get grant money.
Phaaisatroll
Posted - 03/27/24
$ARDS Eric Patzer is looking for a new job. He is the founder and chairman of the board of Aridis. What does he know? Seems like he can't make money with Aridis anymore.
Phaaisatroll
Posted - 03/27/24
$ARDS Astrazeneca wants more pipeline assets for the vaccine and immune therapies group and is hiring somebody who should find these assets.
Phaaisatroll
Posted - 03/27/24
$ARDS i can't see if AstraZeneca is still a shareholder of Aridis. AZ is not listed as a shareholder on fintel but i also can't find that they sold. Is it possible that they don't have to report their holdings of Aridis anymore because its less than 5% of Aridis or because its OTC now? Does anybody know about the regulations when you have to report your holdings of another company?
EsquireTradingCo
Posted - 1 month ago
$ARDS LOL...one dude spamming the board trying to convince people to gamble on a buyout.
Phaaisatroll
Posted - 1 month ago
$ARDS Astrazeneca is in a shopping spree. This time they bought the radiopharmaceutical company Fusion. They already had a cooperation with Fusion but now bought them completely. Astrazeneca also has/had a deal with Aridis so lets see what they will do. Maybe Aridis had to wait because its the smallest buyout and doesn't have priority over the other larger buyouts.
ChiefOptionsTrader
Posted - 1 month ago
$ARDS Any new news here about the latest going on?